Hypersensitivity to the active substance or to any of the excipients listed in Description.
Neonates and infants (less than 2 years of age) (see Adverse Reactions).
Patients receiving monoamine oxidase (MAO) inhibitor therapy and patients on antidepressants which affect noradrenergic transmission (e.g. tricyclic antidepressants and mianserin).